AI assistant
Sending…
NextFerm Technologies Ltd. — Investor Presentation 2025
Jan 15, 2025
6948_rns_2025-01-15_a5e4ea74-1c97-4929-885f-a1a50e01e235.pdf
Investor Presentation
Open in viewerOpens in your device viewer
NEXTFERM TECHNOLOGIES
High-value yeast derived products
Jan - 2025

YEAST DERIVED PRODUCTS \$ MULTI BILLIONS INGREDIENTS MARKET


OUR STRATEGY (INDIAN OPERATION WITH ISRAELI INNOVATION)
Becoming a high-value yeast derived products leader
- Infrastructure Competitive cost structure
- R&D Better products
- Direct access to local Indian market with high barriers for competition
- Global approach and demands
profitability :
- Focus on profitable activities which not require high investments
- Tight OPEX

STRATEGIC PARTNER
JV WITH KOTHARI FOR \$ MULTI BILLIONS YEAST PRODUCTS MARKET
Kothari
Expert in fermentation, it's production infrastructure supporting future growth, efficient, strong position in Indian market
NextFerm
Strong R&D, technological production capabilities, international marketing & sales,
Technological Platform
For producing yeast-derived, innovative, functional vegan food ingredients



OUR PRODUCTS






- We deliver


-Confidential-
YEAST EXTRACTS - FACTS
Market:
- 2 Billion USD/Year
- CAGR 9%
- The Indian opportunity: fast growth, no domestic player, duty protection
Segments:
- Flavors
- Culture Media
NEXT GENERATION
• Yeast protein next generation:
- o Food: soluble (drinks), functional
- o Nutritional: enrichments (minerals, vitamins, nucleotides, lipids)- new
- o Sports nutrition/elderly nutrition: clinical supported formulation
- Yeast extract for flavors:
- o High NMP o New flavors by flavor reactions
- New yeast derived ingredients: o Supplements

THANK YOU!

More from NextFerm Technologies Ltd.
Delisting Announcement
2025
Sep 2
Share Issue/Capital Change
2025
Apr 28
Investor Presentation
2025
Jan 15
Share Issue/Capital Change
2024
Oct 7
Investor Presentation
2024
Apr 16
Investor Presentation
2024
Apr 16
Investor Presentation
2023
Aug 20
Report Publication Announcement
2023
Aug 20
Investor Presentation
2023
Mar 23
Regulatory Filings
2023
Mar 23